>
pdufa.bio

COMP360 psilocybin

Updated ยทnext FDA decision on the calendar

COMP360 psilocybin is a COMPASS Pathways plc program. Its next catalyst is a Readout in Jun 2028. Every date links its source.

CMPS catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: COMPASS Pathways plc (CMPS). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Jun 2028CMPS

Questions

When is COMP360 psilocybin's next FDA decision or readout?

The next tracked catalyst for COMP360 psilocybin is a Readout in Jun 2028.

What happened at COMP360 psilocybin's most recent FDA decision?

No FDA decision for COMP360 psilocybin is in our archive yet.

Who makes COMP360 psilocybin?

COMPASS Pathways plc (CMPS).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.